Walgreens Q4 2021 Earnings Report
Key Takeaways
Walgreens Boots Alliance reported strong Q4 2021 results, exceeding expectations with a 12.8% increase in sales to $34.3 billion and adjusted EPS of $1.17, reflecting robust growth in both the International and United States segments. The company surpassed its COVID-19 vaccination goal, administering 13.5 million vaccinations during the quarter, and achieved over $2 billion in annual cost savings through its Transformational Cost Management Program.
Fourth quarter sales from continuing operations increased 12.8 percent year-over-year to $34.3 billion.
Fourth quarter adjusted EPS increased 29.5 percent to $1.17.
Walgreens surpassed COVID-19 vaccination goal, providing 13.5 million vaccinations in the quarter.
The Transformational Cost Management Program delivered in excess of $2 billion in annual cost savings by fiscal 2021, a year ahead of schedule.
Walgreens
Walgreens
Walgreens Revenue by Segment
Forward Guidance
Company leadership to discuss strategic priorities for the future and fiscal 2022 guidance at Virtual Investor Conference today
Revenue & Expenses
Visualization of income flow from segment revenue to net income